Servier's fiscal 2015/16 sales grow 2.7%

French privately-held drugmaker Servier says that its turnover for the fiscal year 2015/16 grew 2.7% to 4 billion euros ($4.25 billion), of which 2.8 billion euros come from Servier's brand drugs and 1.2 billion euros from generics.

The net profit for the period was 188 million euros, accounting for 5% of turnover, said Servier, which is France’s second largest pharma company and is governed by a foundation and invests all its profits in therapeutic progress to serve patient needs.

This growth can be explained by